125 related articles for article (PubMed ID: 4556589)
1. Changes in fluid intake suggesting depressed appetite in rats with central catecholaminergic lesions.
Sorensen CA; Ellison GD; Masuoka D
Nat New Biol; 1972 Jun; 237(78):279-81. PubMed ID: 4556589
[No Abstract] [Full Text] [Related]
2. Biogenic amines in discrete brain areas after treatment with monoamineoxidase inhibitors.
Valzelli L; Garattini S
J Neurochem; 1968 Mar; 15(3):259-61. PubMed ID: 5638622
[No Abstract] [Full Text] [Related]
3. The intracellular distribution of brain catecholamines.
Gutman Y; Weil-Malherbe H
J Neurochem; 1967 Jun; 14(6):619-25. PubMed ID: 6025094
[No Abstract] [Full Text] [Related]
4. Effect of lateral hypothalamic injections of 6-hydroxydopamine on food and water intake in rats.
Smith GP; Storhmayer AJ; Reis DJ
Nat New Biol; 1972 Jan; 235(53):27-9. PubMed ID: 4553463
[No Abstract] [Full Text] [Related]
5. Identification of dopamine, noradrenaline and 5-hydroxytryptamine varicosities in a fraction containing nerve ending particles.
Fuxe K; Grobecker H; Hökfelt T; Jonsson G
Brain Res; 1967 Nov; 6(3):475-80. PubMed ID: 6076252
[No Abstract] [Full Text] [Related]
6. Consummatory behaviors of hypothalamic hyperphagic rats after central injection of 6-hydroxydopamine.
Coscina DV; Rosenblum-Blinick C; Godse DD; Stancer HC
Pharmacol Biochem Behav; 1973; 1(6):629-42. PubMed ID: 4785805
[No Abstract] [Full Text] [Related]
7. Specific noradrenergic neurones destroyed by 6-hydroxydopamine injection into newborn rats.
Taylor KM; Clark DW; Laverty R; Phelan EL
Nat New Biol; 1972 Oct; 239(95):247-8. PubMed ID: 4507808
[No Abstract] [Full Text] [Related]
8. Levels and distribution of central nervous system amines in normal and morphine-dependent monkeys.
Segal M; Deneau GA; Seevers MH
Neuropharmacology; 1972 Mar; 11(2):211-22. PubMed ID: 4623661
[No Abstract] [Full Text] [Related]
9. Deficits in feeding behavior after intraventricular injection of 6-hydroxydopamine in rats.
Zigmond MJ; Stricker EM
Science; 1972 Sep; 177(4055):1211-4. PubMed ID: 5057630
[TBL] [Abstract][Full Text] [Related]
10. 6-Hydroxydopa depletion of brain norepinephrine and the function of aggressive behavior.
Thoa NB; Eichelman B; Richardson JS; Jacobowitz D
Science; 1972 Oct; 178(4056):75-7. PubMed ID: 4672239
[TBL] [Abstract][Full Text] [Related]
11. Regional differences in (3H)noradrenaline accumulation in monkey brain (Macaca irus).
Gfeller E; Green A; Snyder SH
Brain Res; 1968 Oct; 11(1):263-7. PubMed ID: 4972653
[No Abstract] [Full Text] [Related]
12. On the behavioral and neurochemical actions of 6-hydroxydopa and 5,6-dihydroxytryptamine in rats.
Richardson JS; Cowan N; Hartman R; Jacobowitz DM
Res Commun Chem Pathol Pharmacol; 1974 May; 8(1):29-44. PubMed ID: 4847904
[No Abstract] [Full Text] [Related]
13. Alterations in consummatory behavior following intracisternal injection of 6-hydroxydopamine.
Breese GR; Smith RD; Cooper BR; Grant LD
Pharmacol Biochem Behav; 1973; 1(3):319-28. PubMed ID: 4775860
[No Abstract] [Full Text] [Related]
14. Effect of L-dopa on brain monoamines and their metabolites in Parkinson's disease.
Rinne UK; Sonninen V; Hyyppä M
Life Sci I; 1971 May; 10(10):549-57. PubMed ID: 5580101
[No Abstract] [Full Text] [Related]
15. Stimulation of various forebrain structures and brain 5HT, 5HIAA and behaviour in rats.
Kostowski W; Giacalone E
Eur J Pharmacol; 1969 Aug; 7(2):176-9. PubMed ID: 5345992
[No Abstract] [Full Text] [Related]
16. LH syndrome and brain catecholamine levels after lesions of the nigrostriatal bundle.
Oltmans GA; Harvey JA
Physiol Behav; 1972 Jan; 8(1):69-78. PubMed ID: 4665334
[No Abstract] [Full Text] [Related]
17. Opposed behavioral syndromes in rats with partial and more complete central serotonergic lesions made with 5,6 dihydroxytryptamine.
Diaz J; Ellison G; Masuoka D
Psychopharmacologia; 1974 Jun; 37(1):67-79. PubMed ID: 4414929
[No Abstract] [Full Text] [Related]
18. Distribution of norepinephrine, epinephrine, dopamine, serotonin, 3,4-dihydroxyphenylacetic acid, homovanillic acid and 5-hydroxyindole-3-acetic acid in dog brain.
Mefford IN; Foutz A; Noyce N; Jurik SM; Handen C; Dement WC; Barchas JD
Brain Res; 1982 Mar; 236(2):339-49. PubMed ID: 6175382
[TBL] [Abstract][Full Text] [Related]
19. Effects of 6-hydroxydopamine on putative transmitter substances in the central nervous system.
Jacks BR; de Champlain J; Cordeau JP
Eur J Pharmacol; 1972 May; 18(3):353-60. PubMed ID: 5035623
[No Abstract] [Full Text] [Related]
20. [The role of dopamine in the mechanism of the sedative action of lithium salts].
Zin'kovskaia LIa; Komissarov IV
Zh Nevropatol Psikhiatr Im S S Korsakova; 1975; 75(3):426-30. PubMed ID: 1119285
[No Abstract] [Full Text] [Related]
[Next] [New Search]
